Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
The Clinical Picture

Tuberous sclerosis complex

Jesica Martín Carmona, MD, Elisabeth Gómez Moyano, MD, PhD, Ana Raquel de Castro Almeida, MD and Leandro Martínez Pilar, MD, PhD
Cleveland Clinic Journal of Medicine July 2021, 88 (7) 367-368; DOI: https://doi.org/10.3949/ccjm.88a.20075
Jesica Martín Carmona
Department of Internal Medicine, Hospital Regional Universitario de Málaga, Málaga, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
Elisabeth Gómez Moyano
Department of Dermatology, Hospital Regional Universitario de Málaga, Málaga, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ana Raquel de Castro Almeida
Department of Radiology, Hospital Regional Universitario de Málaga, Málaga, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Leandro Martínez Pilar
Department of Dermatology, Hospital Regional Universitario de Málaga, Málaga, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

A 45-year-old man with an unremarkable medical history was referred to the dermatology department because of facial lesions. On examination, he had multiple erythematous papules in the malar and nasal regions of the face that were judged to be angiofibromas (Figure 1A). He also had linear hypopigmented macules and shagreen patches on the lower back (Figure 1B) and a periungual fibroma on a fingernail (Figure 1C).

Figure 1
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure 1

(A) Multiple erythematous papules in the malar and nasal regions were judged to be angiofibromas. (B) Linear hypopigmented macules and shagreen patches were noted over the lower back, as well as (C) a periungual fibroma on a fingernail. (D) Ultrasonography showed a hyperechoic solid lesion compatible with renal angiomyolipoma (arrow). (E) Brain magnetic resonance imaging detected cortical tubers (arrow) as well-circumscribed frontal and occipital areas of high signal intensity on axial fluid-attenuation inversion-recovery.

Although skin lesions such as these can be found in the general population, they can also be associated with certain syndromes. Having 1 or 2 angiofibromas is common in the general population, but multiple facial angiofibromas are present in 80% of patients who have tuberous sclerosis complex (TSC), for which at least 3 lesions are required as a diagnostic criterion. Angiofibromas can also be observed in Birt-Hogg-Dubé syndrome and in multiple endocrine neoplasia type 1.1 Shagreen patches, a type of collagenoma, are present in Cowden syndrome and in approximately half of patients with TSC. Over 90% of patients with TSC have hypopigmented macules, and the differential diagnosis includes postinflammatory hypopigmentation, piebaldism, and vitiligo.1

A genetic test was requested because we suspected TSC detected deletion of the TSC1 gene, and this finding along with findings on the physical examination confirmed the diagnosis of TSC.

Because people with TSC tend to develop tumors in multiple organs of the body, the patient underwent an extensive workup. Ultra sonography of the kidneys showed a hyperechoic solid lesion compatible with renal angiomyolipoma (Figure 1D, arrow), although the patient’s blood test results detected no renal impairment.

Although the patient did not manifest neurologic or neurobehavioral abnormalities, which are common in patients with TSC, brain magnetic resonance imaging detected cortical tubers as well-circumscribed frontal and occipital areas of high signal-intensity on axial fluid-attenuation inversion-recovery images (Figure 1E, arrow), and low signal-intensity on T1-weighted images, interpreted as cortical tubers. An ophthalmic examination, chest radiography, and echocardiography revealed no abnormalities.

SIGNS AND SYMPTOMS

TSC is a rare disorder with an incidence of 1 in 10,000 live births. It is caused by mutations of tumor-suppressor genes, which can lead to benign hamartomas in the brain, eyes, heart, lung, liver, kidney, and skin.2 The most frequent clinical manifestations are dermatologic lesions such as focal hypopigmentation, angiofibroma, ungual fibroma, and shagreen patches,3 but neurologic manifestations such as epilepsy, neuropsychiatric disorders, and behavioral problems are also common. Renal impairment is seen but is not among the most common early clinical manifestations.

Even though benign tumors are more common, there is a risk of malignancy, especially in the brain and kidney.

DIAGNOSIS AND TREATMENT

Appropriate evaluation is important to limit the morbidity and mortality of TSC. Neurologic and renal involvement are the principal causes of morbidity.2 The evaluation should include brain, lung, and abdominal imaging, a complete blood cell count, and pulmonary function testing. The physical examination includes auscultation for heart murmur or lung crackles and identification of eye disorders or abdominal mass.4

Treatment depends on the clinical features. Inhibitors of the mammalian target of rapamycin pathway are a therapeutic option and can be used as adjuvant therapy for large tumors before surgery.5 Other medical treatments depend on the manifestation (eg, antiepileptic drugs in epilepsy). Surgery is considered for solitary lesions that cannot be controlled with conservative treatment in patients without high surgical risk.

OUR PATIENT’S COURSE

The patient was followed by several specialists to monitor for the appearance of complications, occasionally requiring resection of a skin lesion with local complication.

DISCLOSURES

The authors report no relevant financial relationships which, in the context of their contributions, could be perceived as a potential conflict of interest.

  • Copyright © 2021 The Cleveland Clinic Foundation. All Rights Reserved.

REFERENCES

  1. ↵
    1. Northrup H,
    2. Krueger DA; International Tuberous Sclerosis Complex Consensus Group
    . Tuberous sclerosis complex diagnostic criteria update: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49(4):243–254. doi:10.1016/j.pediatrneurol.2013.08.001
    OpenUrlCrossRefPubMed
  2. ↵
    1. Portocarrero LKL,
    2. Quental KN,
    3. Samorano LP,
    4. Oliveira ZNP,
    5. Rivitti-Machado MCDM
    . Tuberous sclerosis complex: review based on new diagnostic criteria. An Bras Dermatol 2018; 93(3):323–331. doi:10.1590/abd1806-4841.20186972
    OpenUrlCrossRef
  3. ↵
    1. Crino PB,
    2. Nathanson KL,
    3. Henske EP
    . The tuberous sclerosis complex. N Engl J Med 2006; 355(13):1345–1356. doi:10.1056/NEJMra055323
    OpenUrlCrossRefPubMed
  4. ↵
    1. Krueger DA,
    2. Northrup H; International Tuberous Sclerosis Complex Consensus Group
    . Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference. Pediatr Neurol 2013; 49(4):255–265. doi:10.1016/j.pediatrneurol.2013.08.002
    OpenUrlCrossRefPubMed
  5. ↵
    1. Sadowski K,
    2. Kotulska K,
    3. Schwartz RA,
    4. Jóźwiak S
    . Systemic effects of treatment with mTOR inhibitors in tuberous sclerosis complex: a comprehensive review. J Eur Acad Dermatol Venereol 2016; 30(4):586–594. doi:10.1111/jdv.13356
    OpenUrlCrossRef
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 88 (7)
Cleveland Clinic Journal of Medicine
Vol. 88, Issue 7
1 Jul 2021
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Tuberous sclerosis complex
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Tuberous sclerosis complex
Jesica Martín Carmona, Elisabeth Gómez Moyano, Ana Raquel de Castro Almeida, Leandro Martínez Pilar
Cleveland Clinic Journal of Medicine Jul 2021, 88 (7) 367-368; DOI: 10.3949/ccjm.88a.20075

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Tuberous sclerosis complex
Jesica Martín Carmona, Elisabeth Gómez Moyano, Ana Raquel de Castro Almeida, Leandro Martínez Pilar
Cleveland Clinic Journal of Medicine Jul 2021, 88 (7) 367-368; DOI: 10.3949/ccjm.88a.20075
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • SIGNS AND SYMPTOMS
    • DIAGNOSIS AND TREATMENT
    • OUR PATIENT’S COURSE
    • DISCLOSURES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Tinea incognito
  • Prolonged venous filling time and dependent rubor in a patient with peripheral artery disease
  • Sarcoidosis with diffuse purplish erythematous plaques on the hands
Show more The Clinical Picture

Similar Articles

Subjects

  • Cardiology
  • Dermatology
  • Genetics
  • Hematology
  • Hepatology
  • Nephrology
  • Neurology
  • Oncology

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire